• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Neuropsychiatric Symptoms in Parkinson's Disease: Beyond Complications.帕金森病中的神经精神症状：超越并发症
Front Psychiatry. 2016 Jun 23;7:110. doi: 10.3389/fpsyt.2016.00110. eCollection 2016.
2
Neuropsychiatric manifestations of Parkinson's disease.帕金森病的神经精神表现
Australas Psychiatry. 2016 Dec;24(6):529-533. doi: 10.1177/1039856216654393. Epub 2016 Jul 25.
3
A comprehensive overview of the neuropsychiatry of Parkinson's disease: A review.帕金森病神经精神病学综述：一篇综述
Bull Menninger Clin. 2017 Winter;81(1):53-105. doi: 10.1521/bumc.2017.81.1.53.
4
Commentary on "The Neuropsychiatry of Parkinson's Disease: A Perfect Storm".关于《帕金森病的神经精神病学：一场完美风暴》的评论
Am J Geriatr Psychiatry. 2019 Sep;27(9):1019-1021. doi: 10.1016/j.jagp.2019.03.007. Epub 2019 Mar 20.
5
Neuropsychiatric co-morbidities in non-demented Parkinson's disease.非痴呆型帕金森病的神经精神共病
Ann Indian Acad Neurol. 2015 Jan-Mar;18(1):33-8. doi: 10.4103/0972-2327.144287.
6
Activation of N-methyl-D-aspartate receptor glycine site temporally ameliorates neuropsychiatric symptoms of Parkinson's disease with dementia.N-甲基-D-天冬氨酸受体甘氨酸位点的激活可暂时改善伴有痴呆的帕金森病的神经精神症状。
Psychiatry Clin Neurosci. 2014 Sep;68(9):692-700. doi: 10.1111/pcn.12175. Epub 2014 Apr 14.
7
A guide to management of neuropsychiatric manifestations of Parkinson's disease.帕金森病神经精神症状管理指南
Australas Psychiatry. 2016 Dec;24(6):534-537. doi: 10.1177/1039856216654394. Epub 2016 Jun 21.
8
Impact of Neuropsychiatric Symptoms on the Quality of Life of Subjects with Parkinson's Disease.神经精神症状对帕金森病患者生活质量的影响。
J Parkinsons Dis. 2015;5(3):541-8. doi: 10.3233/JPD-150597.
9
Effect of Rivastigmine on Behavioral and Psychiatric Symptoms of Parkinson's Disease Dementia.多奈哌齐对帕金森病痴呆行为和精神症状的影响。
J Mov Disord. 2015 May;8(2):98-102. doi: 10.14802/jmd.15041. Epub 2015 May 31.
10
Range of neuropsychiatric disturbances in patients with Parkinson's disease.帕金森病患者神经精神障碍的范围
J Neurol Neurosurg Psychiatry. 1999 Oct;67(4):492-6. doi: 10.1136/jnnp.67.4.492.

引用本文的文献

1
Diosgenin derivative ML5 attenuates MPTP-induced neuronal impairment via regulating AMPK/PGC-1α-mediated mitochondrial biogenesis and fusion/fission.薯蓣皂苷元衍生物ML5通过调节AMPK/PGC-1α介导的线粒体生物合成及融合/分裂减轻MPTP诱导的神经元损伤。
Am J Transl Res. 2024 Aug 15;16(8):3582-3598. doi: 10.62347/JBRE5043. eCollection 2024.
2
White matter hyperintensities and smaller cortical thickness are associated with neuropsychiatric symptoms in neurodegenerative and cerebrovascular diseases.脑白质高信号和皮质变薄与神经退行性疾病和脑血管病的神经精神症状有关。
Alzheimers Res Ther. 2023 Jun 20;15(1):114. doi: 10.1186/s13195-023-01257-y.
3
Compound Dihuang Granule Inhibits Nigrostriatal Pathway Apoptosis in Parkinson's Disease by Suppressing the JNK/AP-1 Pathway.复方地黄颗粒通过抑制JNK/AP-1信号通路抑制帕金森病黑质纹状体通路细胞凋亡
Front Pharmacol. 2021 Apr 8;12:621359. doi: 10.3389/fphar.2021.621359. eCollection 2021.
4
COVID-19 Pandemic and Psychiatric Symptoms: The Impact on Parkinson's Disease in the Elderly.新冠疫情与精神症状：对老年帕金森病的影响
Front Psychiatry. 2020 Nov 27;11:581144. doi: 10.3389/fpsyt.2020.581144. eCollection 2020.
5
Dopamine Buffering Capacity Imaging: A Pharmacodynamic fMRI Method for Staging Parkinson Disease.多巴胺缓冲能力成像：一种用于帕金森病分期的药效功能磁共振成像方法。
Front Neurol. 2020 May 6;11:370. doi: 10.3389/fneur.2020.00370. eCollection 2020.
6
Da-Bu-Yin-Wan and Qian-Zheng-San Ameliorate Mitochondrial Dynamics in the Parkinson's Disease Cell Model Induced by MPP.大补阴丸和牵正散改善MPP诱导的帕金森病细胞模型中的线粒体动力学。
Front Pharmacol. 2019 Apr 24;10:372. doi: 10.3389/fphar.2019.00372. eCollection 2019.
7
A Systematic Review and Case Series of Ziprasidone for Psychosis in Parkinson's Disease.一项关于齐拉西酮治疗帕金森病相关精神病的系统评价和病例系列研究。
J Parkinsons Dis. 2019;9(1):63-71. doi: 10.3233/JPD-181448.
8
Treatment of Parkinson's disease psychosis.帕金森病精神病的治疗。
Med Int Rev. 2017 Dec;27(109):266-271. Epub 2018 Feb 3.
9
Mapping movement, mood, motivation and mentation in the subthalamic nucleus.绘制丘脑底核中的运动、情绪、动机和心理活动图谱。
R Soc Open Sci. 2018 Jul 18;5(7):171177. doi: 10.1098/rsos.171177. eCollection 2018 Jul.
10
Management of Psychosis in a Patient with Probable Dopa-Responsive Dystonia.疑似多巴反应性肌张力障碍患者的精神病管理
Case Rep Psychiatry. 2018 Jun 14;2018:8040491. doi: 10.1155/2018/8040491. eCollection 2018.

本文引用的文献

1
Review of delirium in patients with Parkinson's disease.帕金森病患者谵妄的综述。
J Neurol. 2015 Nov;262(11):2401-10. doi: 10.1007/s00415-015-7760-1. Epub 2015 May 10.
2
Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial.吡贝地尔治疗帕金森病精神病患者的随机、安慰剂对照 3 期试验。
Lancet. 2014 Feb 8;383(9916):533-40. doi: 10.1016/S0140-6736(13)62106-6. Epub 2013 Nov 1.
3
Risk of Parkinson disease after depression: a nationwide population-based study.抑郁症后患帕金森病的风险：一项全国范围内基于人群的研究。
Neurology. 2013 Oct 22;81(17):1538-44. doi: 10.1212/WNL.0b013e3182a956ad. Epub 2013 Oct 2.
4
The coeruleus/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson's disease.蓝斑/下蓝斑复合体与帕金森病快动眼睡眠行为障碍。
Brain. 2013 Jul;136(Pt 7):2120-9. doi: 10.1093/brain/awt152.
5
EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease.EFNS/MDS-ES/ENS [更正] 帕金森病诊断建议。
Eur J Neurol. 2013 Jan;20(1):16-34. doi: 10.1111/ene.12022.
6
Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment.帕金森病患者的认知障碍：诊断、生物标志物和治疗。
Lancet Neurol. 2012 Aug;11(8):697-707. doi: 10.1016/S1474-4422(12)70152-7.
7
Parkinson's disease: the quintessential neuropsychiatric disorder.帕金森病：典型的神经精神障碍。
Mov Disord. 2011 May;26(6):1022-31. doi: 10.1002/mds.23664.
8
Impulse control disorders in Parkinson's disease: seeking a roadmap toward a better understanding.帕金森病中的冲动控制障碍：寻求更好理解的路线图。
Brain Struct Funct. 2011 Nov;216(4):289-99. doi: 10.1007/s00429-011-0314-0. Epub 2011 May 4.
9
Quetiapine in the treatment of psychosis in Parkinson's disease.喹硫平治疗帕金森病中的精神病。
Ther Adv Neurol Disord. 2010 Nov;3(6):339-50. doi: 10.1177/1756285610389656.
10
Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues.帕金森病的脑深部电刺激：专家共识及关键问题综述
Arch Neurol. 2011 Feb;68(2):165. doi: 10.1001/archneurol.2010.260. Epub 2010 Oct 11.

Neuropsychiatric Symptoms in Parkinson's Disease: Beyond Complications.

作者信息

Kehagia Angie A

机构信息

Institute of Psychiatry, Psychology and Neuroscience, King's College London , London , UK.

出版信息

Front Psychiatry. 2016 Jun 23;7:110. doi: 10.3389/fpsyt.2016.00110. eCollection 2016.

DOI:10.3389/fpsyt.2016.00110
PMID:27445867
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4917535/
Abstract
摘要